Evidence map›Paper›PMID 36985482›Full record

ArticleMolecules (Basel, Switzerland)2023

Molecular Dynamic Analysis of Carbapenem-Resistant

Rasha Elsayim, Abeer S Aloufi, Yosra Modafer, Wafa Ali Eltayb, Alaa Alnoor Alameen, Samah Awad Abdurahim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. A Comprehensive Overview ofInfection and drug resistance · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Rasha ElsayimDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Abeer S AloufiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-7712-0313
Yosra ModaferDepartment of Biology, College of Science, Jazan University, Jazan 45142, Saudi Arabia.
Wafa Ali EltaybBiotechnology Department, Faculty of Science and Technology, Shendi University, Shendi 11111, Nher Anile, Sudan.ORCID 0000-0002-3981-201X
Alaa Alnoor AlameenDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Samah Awad AbdurahimDepartment of Microbiology, College of Medicine, Al-Rayan Colleges, AL Madinah Al Monawara 41411, Saudi Arabia.
King Saud University · SAJazan University · SAPrincess Nourah bint Abdulrahman University · SAShendi University · SD

Funding

The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia RI-44-0256.
6 · The paper itself

Abstract

To prevent the rapidly increasing prevalence of bacterial resistance, it is crucial to discover new antibacterial agents. The emergence of

Indexed as

Metal NanoparticlesNanoparticlesPneumoniaZinc OxideAnti-Bacterial AgentsCarbapenemsCefepimeHumansImipenemKlebsiellaKlebsiella pneumoniaeLigandsMeropenemMicrobial Sensitivity TestsMolecular Dynamics SimulationMonobactamsAnti-Bacterial AgentsCarbapenemsCefepimeImipenemLigandsMeropenemMonobactamsPorinsZinc Oxidegreen synthesisKlebsiella pneumoniae carbapenemasemolecular dynamicsmultidrug-resistantzinc oxide nanoparticles

Identifiers

PMID36985482
PMCPMC10055515
OpenAlexW4323854054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.